NL-OMON29614已完成不适用
Anti-VEGF (bevacizumab/ranibizumab) versus RPE-choroid graft in the treatment of 1) non-responders to 3 intravitreal anti-VEGF injections, or 2) patients with AMD and pigment epithelium rip, or 3) patients with AMD and massive haemorrhage. A randomized trial.
Oogziekenhuis Rotterdam (OZR)0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 240
研究概览
简要总结
van Zeeburg EJ, Maaijwee K, van Meurs JC. There is no relation between the occurrence of proliferative vitreoretinopathy and the location of the donor site after transplantation of a free autologous retinal pigment epithelium-choroid graft. Acta Ophthalmol. 2014; 92(3): 228- 231. PMID: 23890210
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Informed consent;
- •2. Age > 65 years;
排除标准
- •1. Haemorrhage or PED secondary to:
- •A. Retinal angiomatous proliferation;
研究者
相似试验
已完成
3 期
Anti-VEGF (bevacizumab/ranibizumab) versus RPE-choroid graft in the treatment of 1) non-responders to 3 intravitreal anti-VEGF injections, or 2) patients with AMD and pigment epithelium rip, or 3) patients with AMD and massive haemorrhage. A randomized trial.age-relatede macular degeneration10047060NL-OMON33994Oogziekenhuis Rotterdam40
进行中（未招募）
1 期
Anti-VEGF (bevacizumab/ranibizumab) versus RPE-choroid graft in the treatment of 1) non-responders to 3 intravitreal anti-VEGF injections, or 2) patients with AMD and pigment epithelium rip, or 3) patients with AMD and massive haemorrhage. A randomized trial. - Anti-VEGF versus RPE-choroid graftAge related macular degeneration and either of the following conditions:1) not responding to 3 intravitreal anti-VEGF injections, or 2) pigment epithelium rip, or 3) massive haemorrhage.EUCTR2008-008259-41-NLRotterdam Eye Hospital20
暂停
不适用
The effect of an anti-VEGF drug on proliferative diabetic retinopathy complicated with diabetic macular edemaproliferative diabetic retinopathy complicated with diabetic macular edemaJPRN-UMIN000027618Tokyo Women's Medical University30
已完成
不适用
Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucomaISRCTN12125882Horten Center, University of Zurich (Switzerland)50
终止
不适用
Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor DynamicsMacular DiseaseNCT01994174University of Nebraska13